ChemicalBook > CAS DataBase List > PROTAC B-Raf degrader 1

PROTAC B-Raf degrader 1

Product Name
PROTAC B-Raf degrader 1
CAS No.
2364367-27-9
Chemical Name
PROTAC B-Raf degrader 1
Synonyms
PROTAC B-Raf degrader 1;N-({[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]carbamoyl}methyl)-2-[(2-methoxy-5-{[(1E)-2-(2,4,6-trimethoxyphenyl)ethenesulfonyl]methyl}phenyl)amino]acetamide
CBNumber
CB25848913
Molecular Formula
C36H37N5O12S
Formula Weight
763.77
MOL File
Mol file
More
Less

PROTAC B-Raf degrader 1 Property

Boiling point:
1136.9±65.0 °C(Predicted)
Density 
1.451±0.06 g/cm3(Predicted)
storage temp. 
Store at -20°C, stored under nitrogen
solubility 
DMSO : 25 mg/mL (32.73 mM; Need ultrasonic)
pka
10.68±0.40(Predicted)
form 
Solid
color 
Light yellow to yellow
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

ChemScene
Product number
CS-0090791
Product name
PROTACB-Rafdegrader1
Purity
99.18%
Packaging
5mg
Price
$580
Updated
2021/12/16
ChemScene
Product number
CS-0090791
Product name
PROTACB-Rafdegrader1
Purity
99.18%
Packaging
10mg
Price
$980
Updated
2021/12/16
More
Less

PROTAC B-Raf degrader 1 Chemical Properties,Usage,Production

Biological Activity

PROTAC B-Raf degrader 1 (compound 2) is a proteolysis targeting chimera (PROTAC) for the degradation of B-Raf based on Cereblon ligand with anti-cancer activity[1]. The IC50 values of PROTAC B-Raf degrader 1 (compound 2) towards MCF-7, MDA-MB-231, HepG2, LO2 and B16 cells are 2.7 μM, 21.21 μM, 18.70 μM, 41.11μM and 22.68 μM, respectively[1].PROTAC B-Raf degrader 1 (5 or 10 μM) can accelerate the degradation of B-Raf by recruiting ubiquitin-proteasome system, and further affects the expression of Mcl-1, a downstream protein of B-Raf[1].MCF-7 cells achieve an apoptosis rate of 76.70% (64.00% early apoptosis, 12.70% late apoptosis) after 24 h incubation of PROTAC B-Raf degrader 1 with the concentration of 20 μM[1].PROTAC B-Raf degrader 1 arrests cell cycle at the G2/M phase[1].

References

[1]. Chen H, et al. Pomalidomide hybrids act as proteolysis targeting chimeras: Synthesis, anticancer activity and B-Raf degradation. Bioorg Chem. 2019 Mar 19;87:191-199.

PROTAC B-Raf degrader 1 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

PROTAC B-Raf degrader 1 Suppliers

TargetMol Chemicals Inc.
Tel
+1-781-999-5354 +1-00000000000
Email
marketing@targetmol.com
Country
United States
ProdList
32165
Advantage
58

2364367-27-9, PROTAC B-Raf degrader 1Related Search:


  • PROTAC B-Raf degrader 1
  • N-({[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]carbamoyl}methyl)-2-[(2-methoxy-5-{[(1E)-2-(2,4,6-trimethoxyphenyl)ethenesulfonyl]methyl}phenyl)amino]acetamide
  • 2364367-27-9